Skip to main content
Premium Trial:

Request an Annual Quote

Proteomics International, Australian Organizations Launching A$4M Research Facility

NEW YORK – Proteomics International said Tuesday that it has partnered with Bioplatforms Australia and the University of Western Australia to launch a laboratory focused on research into clinical and agricultural protein biomarkers. Bioplatforms Australia invests in the life sciences market with a focus on genomics, proteomics, metabolomics, and bioinformatics.

The three entities will invest more than A$4 million ($2.7M) over the next four years to develop the lab, which will be housed in the Western Australian Proteomic Facility and run by Proteomics International and the University of Western Australia.

The partners will investigate protein markers with applications in medicine as well as agricultural, environmental, and marine science and provide expertise for Western Australia-based researchers.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more